Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study.
Journal
The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
03
01
2020
revised:
31
03
2020
accepted:
01
04
2020
entrez:
22
6
2020
pubmed:
22
6
2020
medline:
17
7
2020
Statut:
ppublish
Résumé
Delayed treatment for first episodes of psychosis predicts worse outcomes. We hypothesised that delaying treatment makes all symptoms more refractory, with harm worsening first quickly, then more slowly. We also hypothesised that although delay impairs treatment response, worse symptoms hasten treatment, which at presentation mitigates the detrimental effect of treatment delay on symptoms. In this longitudinal analysis and modelling study, we included two longitudinal cohorts of patients with first-episode psychosis presenting to English early intervention services from defined catchments: NEDEN (recruiting 1003 patients aged 14-35 years from 14 services between Aug 1, 2005, and April 1, 2009) and Outlook (recruiting 399 patients aged 16-35 years from 11 services between April 1, 2006, and Feb 28, 2009). Patients were assessed at baseline, 6 months, and 12 months with the Positive and Negative Symptom Scale (PANSS), Calgary Depression Scale for Schizophrenia, Mania Rating Scale, Insight Scale, and Social and Occupational Functioning Assessment Scale. Regression was used to compare different models of the relationship between duration of untreated psychosis (DUP) and total symptoms at 6 months. Growth curve models of symptom subscales tested predictions arising from our hypotheses. We included 948 patients from the NEDEN study and 332 patients from the Outlook study who completed baseline assessments and were prescribed dopamine antagonist antipsychotics. For both cohorts, the best-fitting models were logarithmic, describing a curvilinear relationship of DUP to symptom severity: longer DUP predicted reduced treatment response, but response worsened more slowly as DUP lengthened. Increasing DUP by ten times predicted reduced improvement in total symptoms (ie, PANSS total) by 7·339 (95% CI 5·762 to 8·916; p<0·0001) in NEDEN data and 3·846 (1·689 to 6·003; p=0·0005) in Outlook data. This was true of treatment response for all symptom types. Nevertheless, longer DUP was not associated with worse presentation for any symptoms except depression in NEDEN (coefficients 0·099 [95% CI 0·033 to 0·164]; p=0·0028 in NEDEN and 0·007 [-0·081 to 0·095]; p=0·88 in Outlook). Long DUP was associated with reduced treatment response across subscales, consistent with a harmful process upstream of individual symptoms' mechanisms; response appeared to worsen quickly at first, then more slowly. These associations underscore the importance of rapid access to a comprehensive range of treatments, especially in the first weeks after psychosis onset. UK Department of Health, National Institute of Health Research, and Medical Research Council.
Sections du résumé
BACKGROUND
Delayed treatment for first episodes of psychosis predicts worse outcomes. We hypothesised that delaying treatment makes all symptoms more refractory, with harm worsening first quickly, then more slowly. We also hypothesised that although delay impairs treatment response, worse symptoms hasten treatment, which at presentation mitigates the detrimental effect of treatment delay on symptoms.
METHODS
In this longitudinal analysis and modelling study, we included two longitudinal cohorts of patients with first-episode psychosis presenting to English early intervention services from defined catchments: NEDEN (recruiting 1003 patients aged 14-35 years from 14 services between Aug 1, 2005, and April 1, 2009) and Outlook (recruiting 399 patients aged 16-35 years from 11 services between April 1, 2006, and Feb 28, 2009). Patients were assessed at baseline, 6 months, and 12 months with the Positive and Negative Symptom Scale (PANSS), Calgary Depression Scale for Schizophrenia, Mania Rating Scale, Insight Scale, and Social and Occupational Functioning Assessment Scale. Regression was used to compare different models of the relationship between duration of untreated psychosis (DUP) and total symptoms at 6 months. Growth curve models of symptom subscales tested predictions arising from our hypotheses.
FINDINGS
We included 948 patients from the NEDEN study and 332 patients from the Outlook study who completed baseline assessments and were prescribed dopamine antagonist antipsychotics. For both cohorts, the best-fitting models were logarithmic, describing a curvilinear relationship of DUP to symptom severity: longer DUP predicted reduced treatment response, but response worsened more slowly as DUP lengthened. Increasing DUP by ten times predicted reduced improvement in total symptoms (ie, PANSS total) by 7·339 (95% CI 5·762 to 8·916; p<0·0001) in NEDEN data and 3·846 (1·689 to 6·003; p=0·0005) in Outlook data. This was true of treatment response for all symptom types. Nevertheless, longer DUP was not associated with worse presentation for any symptoms except depression in NEDEN (coefficients 0·099 [95% CI 0·033 to 0·164]; p=0·0028 in NEDEN and 0·007 [-0·081 to 0·095]; p=0·88 in Outlook).
INTERPRETATION
Long DUP was associated with reduced treatment response across subscales, consistent with a harmful process upstream of individual symptoms' mechanisms; response appeared to worsen quickly at first, then more slowly. These associations underscore the importance of rapid access to a comprehensive range of treatments, especially in the first weeks after psychosis onset.
FUNDING
UK Department of Health, National Institute of Health Research, and Medical Research Council.
Identifiants
pubmed: 32563307
pii: S2215-0366(20)30147-4
doi: 10.1016/S2215-0366(20)30147-4
pmc: PMC7606908
pii:
doi:
Substances chimiques
Antipsychotic Agents
0
Dopamine Antagonists
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
602-610Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4·0 license. Published by Elsevier Ltd.. All rights reserved.
Références
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
Psychol Med. 2009 Dec;39(12):1943-55
pubmed: 19627645
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Lancet. 2013 Sep 14;382(9896):951-62
pubmed: 23810019
Aust N Z J Psychiatry. 2017 May;51(5):455-476
pubmed: 27733710
Acta Psychiatr Scand. 1994 Jan;89(1):62-7
pubmed: 7908156
Psychol Med. 2003 Jan;33(1):97-110
pubmed: 12537041
Br J Psychiatry Suppl. 1993 Dec;(22):39-44
pubmed: 8110442
Neurosci Lett. 2018 Mar 16;669:59-67
pubmed: 27717830
Am J Psychiatry. 2016 Apr 1;173(4):362-72
pubmed: 26481174
Schizophr Bull. 2018 Oct 17;44(6):1362-1372
pubmed: 29373755
Schizophr Res. 2012 Dec;142(1-3):12-9
pubmed: 23025994
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Br J Psychiatry. 2010 May;196(5):377-82
pubmed: 20435964
Br J Psychiatry. 2006 Nov;189:446-52
pubmed: 17077436
Schizophr Res. 2012 Nov;141(2-3):215-21
pubmed: 23006501
Br J Psychiatry. 2008 Sep;193(3):203-9
pubmed: 18757977
Psychiatry Res. 2014 Nov 30;219(3):420-5
pubmed: 24999174
Arch Gen Psychiatry. 2008 Jun;65(6):634-40
pubmed: 18519821
Br J Psychiatry. 2000 Dec;177:511-5
pubmed: 11102325
Psychol Med. 2018 Jul;48(10):1592-1607
pubmed: 29173201
Psychiatry Res. 2011 May 15;187(1-2):42-8
pubmed: 21168920
J Psychiatr Res. 2016 Jun;77:15-21
pubmed: 26950643
Arch Gen Psychiatry. 2005 Sep;62(9):975-83
pubmed: 16143729
Br J Psychiatry. 2013 Jan;202(1):35-41
pubmed: 23174515
Early Interv Psychiatry. 2014 Feb;8(1):59-67
pubmed: 23347742
Br J Psychiatry. 2014 Aug;205(2):88-94
pubmed: 25252316